Trials / Terminated
TerminatedNCT00480077
Diagnostic Outcome Trial in Heart Failure (DOT-HF Trial)
Diagnostic Outcome Trial in Heart Failure
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 335 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The DOT-HF trial is an international, prospective, multi-center, randomized, controlled trial.
Detailed description
The study was designed with a Control Arm in order to adequately study the effect of early intervention triggered by the OptiVol® Alert and/or SentryCheck™ Monitor/PatientLook™ Indicator and evaluation using OptiVol® Fluid Status Monitoring with Cardiac Compass. OptiVol® Fluid Status Monitoring with Cardiac Compass features are available in the per Clinical Investigational Plan specified Medtronic products (CRT, CRT-D and ICD devices)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Programming (CRT-D, ICD OptiVol® and Cardiac Compass® ) | OptiVol® Fluid status Monitoring with Cardiac Compass |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2007-05-30
- Last updated
- 2025-07-02
- Results posted
- 2019-02-19
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00480077. Inclusion in this directory is not an endorsement.